Abstract:
A seed light source for use in Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes a multi-channel quantum dot laser for generating a multi-channel seed light comprising a plurality of respective channel seed lights. Each channel seed light corresponds to a respective channel of the WDM-PON.
Abstract:
The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and methods of using the compounds, prodrugs and pharmaceutical compositions in the treatment of diseases related to lipid metabolism including diabetes, Non-Alcholic Fatty Liver Disease (NAFLD), Non-Alcholic Steathohepatitis (NASH), diseases caused by abnormal cell proliferation including cancer, psoriasis, and infectious diseases.
Abstract:
A Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes: a respective Optical Network Terminal (ONT) at each one of a plurality of customer sites, each ONT comprising an ONT Fabry Perot (F-P) laser for generating a respective broadband multi-mode uplink optical signal; and an Array Waveguide Grating (AWG) for receiving each broadband multi-mode uplink optical signal through a respective branch port, and for multiplexing a portion of each received broadband multi-mode uplink optical signal into a Wavelength Division Multiplexed (WDM) signal. Each ONT F-P laser is non-injection locked. A gain of each ONT F-P laser is sufficiently inhomogeneous that the modes of the respective broadband multi-mode uplink optical signal are independent. A filter function of the AWG includes a pass band that encompasses at least one mode of a broadband multi-mode uplink optical signal.
Abstract:
A method of estimating an injection power of seed light injected into an injection-seeded transmitter. A back face monitoring (BFM) response of the injection-seeded transmitter is determined, and data representative of the BFM response stored in a memory. During run-time, a controller of the injection-seeded transmitter, detects a temperature of the injection-seeded transmitter and an instantaneous BFM current. BFM response data is obtained from the memory based on the detected temperature, and the seed light injection power estimated based on the obtained data and the detected instantaneous BFM current.
Abstract:
A Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes a plurality of broadband light sources, each broadband light source being connected to receive a respective data signal and generating a corresponding modulated broadband optical signal. An Array Waveguide Grating (AWG) is connected for receiving each modulated broadband optical signal through a respective branch port and for generating a filtered broadband signal. The AWG implements a filter function comprising a respective pass-band associated with each branch port such that the filtered broadband signal exhibits a respective intensity peak associated with each pass-band. Each intensity peak is modulated with data from a respective one of the broadband light sources. A bandwidth of the respective modulated broadband optical signal generated by each broadband light source is at least equal to the width of a channel-band of the AWG.
Abstract:
In a Wavelength Division Multiplexed Passive Optical Network (WDM-PON) including, a system for overlaying an analog broadcast signal. An Optical Line Terminal of the WDM-PON includes a broadband light source for generating uplink seed light for each uplink channel of the WDM-PON, and a modulator for modulating the analog broadcast signal onto the uplink seed light. An Optical Network Terminal of the WDM-PON receives the uplink seed light from the Optical Line Terminal, and includes an optical divider for dividing the received seed light into a first signal and a second signal; a light source for generating an uplink data signals using the first signal as seed light; and an RF receiver for detecting the analog broadcast signal modulated on the second signal.
Abstract:
The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
Abstract:
A discretely tunable locally seeded laser device is provided. The discretely tunable locally seeded laser device comprises: a first tunable laser comprising first discrete output modes; and, a second tunable laser arranged to receive output from the first tunable laser, but otherwise optically isolated from the first tunable laser, the second tunable laser comprising second discrete output modes, such that one first discrete output mode can optically seed an aligned second discrete output mode in a given position of one or more of the first discrete output modes and the second discrete output modes, the aligned second discrete output mode comprising a dominant output.
Abstract:
A method of estimating an injection power of seed light injected into an injection-seeded transmitter. A back face monitoring (BFM) response of the injection-seeded transmitter is determined, and data representative of the BFM response stored in a memory. During run-time, a controller of the injection-seeded transmitter, detects a temperature of the injection-seeded transmitter and an instantaneous BFM current. BFM response data is obtained from the memory based on the detected temperature, and the seed light injection power estimated based on the obtained data and the detected instantaneous BFM current.
Abstract:
The present invention is directed to a compound of Formula (I) wherein Cy1, Cy2, L1, L2, and R1 are as defined herein, a pharmaceutical composition comprising a pharmaceutically effective amount of one or more compounds according to Formula (I) in admixture with a pharmaceutically acceptable carrier, and a method of treating a patient suffering from a PGD2-mediated disorder including, but not limited to, allergic disease (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (such as scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis and the like by administering to said patient a pharmaceutically effective amount of a compound according to Formula (I).